Skip to main content
Skip to section navigation
Skip to footer
Company
About PolarityTE
Management
Board of Directors
R & D
Our Technology
Our Focus on Complex Wounds
Scientific Presentations and Publications
Patients & Families
Our Mission
Expanded Access Program
Research
Clinical Trials
Investors & News
News & Events
Contacts
Financial Info
Stock Data
SEC Filings
Governance
Clinical Trials & Pipeline
Clinical Trials
Our Pipeline
Join Our Team
Contact
Company
About PolarityTE
Management
Board of Directors
R & D
Our Technology
Our Focus on Complex Wounds
Scientific Presentations and Publications
Patients & Families
Our Mission
Expanded Access Program
Research
Clinical Trials
Investors & News
News & Events
Contacts
Financial Info
Stock Data
SEC Filings
Governance
Clinical Trials & Pipeline
Clinical Trials
Our Pipeline
Join Our Team
Contact
Financial Information
Investors
Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Presentations
Contacts
Financial Info
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Executive Team
Board of Directors
Board Committees
Governance Documents
Whistleblower Policy
Latest Financial Results
Q3 2022
Quarter Ended Sep 30, 2022
Earnings Release
PDF
HTML
10-Q
Filing
PDF
HTML
XBRL
ZIP
XLS
Latest 10-K
View HTML
View PDF
Financials
View the latest financials
Income Statement
Balance Sheet
Cash Flow
Email Alerts
Contacts
RSS News Feed
©
2023
PolarityTE, Inc. All Rights Reserved. Patents Pending.
Privacy Policy
|
PO Terms
|
Distributors
|
Purchase Agreement Terms
|
Disclaimer